Search research articles
Contact Us
Filters
Showing results (41-50 of 662) with videos related to
Page
of 67
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 30, 2013
Treatment of methicillin-susceptible Staphylococcus aureus osteoarticular and prosthetic joint infections: using the oxacillin minimum inhibitory concentration to guide appropriate ceftriaxone use
Hien M Nguyen, Ronald N Jones
Journal of Drugs in Dermatology : JDD
|
November 23, 2005
Importance of understanding pharmacokinetic/pharmacodynamic principles in the emergence of resistances, including community-associated Staphylococcus aureus
Thomas R Fritsche, Ronald N Jones
International Journal of Antimicrobial Agents
|
May 15, 2002
Antimicrobial susceptibility of inducible AmpC beta-lactamase-producing Enterobacteriaceae from the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) Programme, Europe 1997-2000
Michael A Pfaller, Ronald N Jones,
Diagnostic Microbiology and Infectious Disease
|
August 2, 2002
Evaluation of in vitro susceptibility testing criteria for gemifloxacin when tested against Haemophilus influenzae strains with reduced susceptibility to ciprofloxacin and ofloxacin
Douglas J Biedenbach, Ronald N Jones
Diagnostic Microbiology and Infectious Disease
|
July 18, 2003
Antagonism between penicillin and erythromycin against Streptococcus pneumoniae: does it exist?
Lalitagauri M Deshpande, Ronald N Jones
Diagnostic Microbiology and Infectious Disease
|
May 6, 2003
Comparative activity of garenoxacin (BMS 284756), a novel desfluoroquinolone, tested against 8,331 isolates from community-acquired respiratory tract infections: North American results from the SENTRY Antimicrobial Surveillance Program (1999-2001)
Ronald N Jones, Douglas J Biedenbach
Diagnostic Microbiology and Infectious Disease
|
May 14, 2003
Five-year analysis of Haemophilus influenzae isolates with reduced susceptibility to fluoroquinolones: prevalence results from the SENTRY antimicrobial surveillance program
Douglas J Biedenbach, Ronald N Jones
Diagnostic Microbiology and Infectious Disease
|
September 5, 2006
Contemporary activity of meropenem and comparator broad-spectrum agents: MYSTIC program report from the United States component (2005)
Paul R Rhomberg, Ronald N Jones
Archives of Pathology & Laboratory Medicine
|
June 3, 2006
Performance accuracy of antibacterial and antifungal susceptibility test methods: report from the College of American Pathologists Microbiology Surveys Program (2001-2003)
Michael A Pfaller, Ronald N Jones,
Diagnostic Microbiology and Infectious Disease
|
September 15, 2009
Antimicrobial susceptibility of Gram-positive bacteria isolated from US medical centers: results of the Daptomycin Surveillance Program (2007-2008)
Helio S Sader, Ronald N Jones
Page
of 67
Search research articles
Search
Showing results (41-50 of 662) with videos related to
Sort By:
Page
of 67
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 30, 2013
Treatment of methicillin-susceptible Staphylococcus aureus osteoarticular and prosthetic joint infections: using the oxacillin minimum inhibitory concentration to guide appropriate ceftriaxone use
Hien M Nguyen, Ronald N Jones
Journal of Drugs in Dermatology : JDD
|
November 23, 2005
Importance of understanding pharmacokinetic/pharmacodynamic principles in the emergence of resistances, including community-associated Staphylococcus aureus
Thomas R Fritsche, Ronald N Jones
International Journal of Antimicrobial Agents
|
May 15, 2002
Antimicrobial susceptibility of inducible AmpC beta-lactamase-producing Enterobacteriaceae from the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) Programme, Europe 1997-2000
Michael A Pfaller, Ronald N Jones,
Diagnostic Microbiology and Infectious Disease
|
August 2, 2002
Evaluation of in vitro susceptibility testing criteria for gemifloxacin when tested against Haemophilus influenzae strains with reduced susceptibility to ciprofloxacin and ofloxacin
Douglas J Biedenbach, Ronald N Jones
Diagnostic Microbiology and Infectious Disease
|
July 18, 2003
Antagonism between penicillin and erythromycin against Streptococcus pneumoniae: does it exist?
Lalitagauri M Deshpande, Ronald N Jones
Diagnostic Microbiology and Infectious Disease
|
May 6, 2003
Comparative activity of garenoxacin (BMS 284756), a novel desfluoroquinolone, tested against 8,331 isolates from community-acquired respiratory tract infections: North American results from the SENTRY Antimicrobial Surveillance Program (1999-2001)
Ronald N Jones, Douglas J Biedenbach
Diagnostic Microbiology and Infectious Disease
|
May 14, 2003
Five-year analysis of Haemophilus influenzae isolates with reduced susceptibility to fluoroquinolones: prevalence results from the SENTRY antimicrobial surveillance program
Douglas J Biedenbach, Ronald N Jones
Diagnostic Microbiology and Infectious Disease
|
September 5, 2006
Contemporary activity of meropenem and comparator broad-spectrum agents: MYSTIC program report from the United States component (2005)
Paul R Rhomberg, Ronald N Jones
Archives of Pathology & Laboratory Medicine
|
June 3, 2006
Performance accuracy of antibacterial and antifungal susceptibility test methods: report from the College of American Pathologists Microbiology Surveys Program (2001-2003)
Michael A Pfaller, Ronald N Jones,
Diagnostic Microbiology and Infectious Disease
|
September 15, 2009
Antimicrobial susceptibility of Gram-positive bacteria isolated from US medical centers: results of the Daptomycin Surveillance Program (2007-2008)
Helio S Sader, Ronald N Jones
Page
of 67